Umberto Basso
机构:Istituto Oncologico Veneto, Istituti di Ricovero e Cura a Carattere Scientifico · ORCID:0000-0002-5075-2177
发表论文 489 篇 · 总被引 11464 次 · h-index 51
代表论文
- Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study (2025 · Cancer Immunology Immunotherapy · 被引 10)
- Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study (2025 · Cancer Immunology Immunotherapy · 被引 10)
- Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer (2025 · Clinical Cancer Research · 被引 6)
- Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trial (2025 · ESMO Open · 被引 6)
- Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: technical aspects and primary staging setting (2025 · Clinical and Translational Imaging · 被引 5)
- Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1) (2025 · Cancer Immunology Immunotherapy · 被引 5)